官方服务：
资源简介：
Access database and original data files of data from the National Radiotherapy Data Set
应用场景：
相关数据集
A phase 1 study of the CD40 agonist MEDI5083 in combination with durvalumab in patients with advanced solid tumors
Aim: This first-in-human study evaluated safety and efficacy of CD40 agonist MEDI5083 with durvalumab in patients with advanced solid tumors. Methods: Patients received MEDI5083 (3–7.5 m
DataCite Commons2024-10-03 更新110
Treatment characteristics.
Key: CRT, concurrent chemoradiation; EBRT, external-beam radiation therapy; EQD2, Equivalent dose in 2Gy fractions; AP/PA, anterioposterior/posterioanterior; HDR, high-dose-rate; LDR, low-dose-rate.
Figshare2015-12-02 更新60
Supplementary Material for: Comparison of Multiple Treatment Planning Techniques for High-Grade Glioma Tumors Near to Critical Organs
Aim: The purpose of this study was to compare 6 treatment planning methods (5-beam coplanar intensitymodulated radiotherapy (IMRT), 7-beam coplanar IMRT, 7-beam noncoplanar IMRT, 2 full arc coplanar v
DataCite Commons2020-08-28 更新50
Plan Evaluator (Sample Video)
This video presents the plan evaluator script package (PE) that runs on a sample lung SBRT plan and plan sum with another plan, which the PE identified as "Lung SBRT" so that it also creates special p
Mendeley Data2024-01-31 更新90
Phase II study of biweekly cetuximab and irinotecan as third-line therapy in patients with pre-treated KRAS exon2 wild-type metastatic colorectal cancer
Interventions: Cetuximab 500 mg/M2/2week Irinotecan 150 mg/M2/2week Primary outcome(s): Response rate Study Design: Single arm Non-randomized
NIAID Data Ecosystem50
